Equities

Sareum Holdings PLC

Sareum Holdings PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)10.99
  • Today's Change-3.51 / -24.21%
  • Shares traded6.06m
  • 1 Year change-87.44%
  • Beta-0.8120
Data delayed at least 20 minutes, as of Mar 28 2024 13:51 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Jun 30 2023202320222021
OPERATIONS
Net income(4.02)(2.58)(1.72)
Depreciation/depletion0.000.000.00
Non-Cash items0.000.000.01
Cash taxes paid, supplemental(0.41)(0.22)(0.13)
Cash interest paid, supplemental------
Changes in working capital0.760.450.13
Total cash from operations(3.27)(2.13)(1.57)
INVESTING
Capital expenditures00.000
Other investing and cash flow items, total00.00(0.04)
Total cash from investing00.00(0.04)
FINANCING
Financing cash flow items------
Total cash dividends paid------
Issuance (retirement) of stock, net03.712.49
Issuance (retirement) of debt, net------
Total cash from financing03.712.49
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash(3.27)1.580.88
Net cash-begin balance/reserved for future use4.262.691.80
Net cash-end balance/reserved for future use0.994.262.69
SUPPLEMENTAL INCOME
Depreciation, supplemental0.000.000.00
Cash interest paid, supplemental------
Cash taxes paid, supplemental(0.41)(0.22)(0.13)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.